HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?

Kidney Transplant Safe Between People With HIV

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Turning the COVID-19 Conversation Into One on Overall Health

As patients return to their routines of returning to pharmacies and the inevitable discussions about COVID-19 begin, it may be a good time to discuss the range of tests that the CDC recommends.

Integrase Strand Transfer Inhibitors Associated With Weight Gain in Patients With HIV

Globally, dolutegravir is expected to be a part of treatment for approximately 15 million people living with HIV by 2021.

Antiretroviral Therapy, Anticoagulants in HIV-infected Patients for Stroke Prevention in Atrial Fibrillation

Significant morbidity and mortality are associated with an aging population due to cardiovascular disease, which is very common in HIV-infected persons.

FDA Approves Fostemsavir for HIV Treatment

Fostemsavir is indicated for adults with drug resistant HIV.

FDA Approves Dolutegravir for Infants, Children with HIV

Dolutegravir tablets are intended to treat pediatric patients at least 4 weeks old and at least 6 pounds who have never been treated for HIV or who have been treated, but not with an integrase strand transferase inhibitor class drug, according to the press release.

Breakthrough in HIV Research Creates New Path to Better Therapies

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

Pharmacy Heroes: Team Cares for Patients with HIV/AIDS, HCV, Other Illnesses Amid COVID-19 Pandemic

Today, we’re celebrating the clinical pharmacy specialist team at the William J. Holloway Community Program in Delaware.

The High Cost of Hepatitis C Infection

The 2 most common, recommended, and simplified treatments for HCV are glecaprevir/pibrentasvir (Mavyret) and sofosbuvir/velpatasvir (Epclusa).

Study Shows Anti-Parasitic Drug Can Kill COVID-19 Virus in Cell Culture

The widely available anti-parasitic drug ivermectin is capable of killing COVID-19 within 48 hours in a cell culture, according to a new study.

Interactives: Case Studies (March 2020)

What would you recommend for these patients?

Study Suggests Second Patient Cured from HIV Through Stem Cell Transplantation

A study of the second HIV patient to undergo successful stem cell transplantation from donors with an HIV-resistant gene found that there was no active viral infection in the patient’s blood 30 months after they stopped antiretroviral therapy.

Medication adherence plays a vital role in the success, or failure, of patients with HIV/AIDS. This Pharmacy Times® specialty page serves as a hub for all clinical news that pharmacists need to know about HIV treatment and possible prevention. The coverage includes breaking news coverage of approvals from the US Food and Drug Administration, key takeaways from the latest novel therapies in clinical trials, and notifications of updates to clinical guidelines for the conditions. Additionally, this page provides suggestions for ways that pharmacists can collaborate with physicians to help overall continued care.